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Astrocytes, one of the predominant types of glial cells, func-
tion as both supportive and metabolic cells for the brain. Under 
cerebral ischemia/reperfusion-induced oxidative conditions, astro-
cytes  accumulate  and  activate  in  the  ischemic  region.  DJ-1  has 
recently been shown to be a sensor of oxidative stress in living cells. 
However, the function of astrocytic DJ-1 is still unknown. In the 
present study, to clarify the effect of astrocytic DJ-1 protein under 
massive oxidative insult, we used a focal ischemic rat model that 
had been subjected to middle cerebral artery occlusion (MCAO) 
and reperfusion. We then investigated changes in the distribution 
of DJ-1 in astrocytes, DJ-1 release from cultured astrocytes, and the 
effects of recombinant DJ-1 protein on hydrogen peroxide (H2O2)-
induced death in normal and DJ-1-knockdown SH-SY5Y cells and 
on in vitro scavenging of hydroxyl radicals (•OH) by electron spin 
resonance spectrometry. At 24 h after 2-h MCAO and reperfusion, 
an  infarct  lesion  was  markedly  observed  using  magnetic  reso-
nance  imaging  and  2,3,5-triphenyltetrazolium  chloride  staining. 
In addition, reactive astrocytes enhanced DJ-1 expression in the 
penumbral zone of the ischemic core and that DJ-1 protein was 
extracellularly released from astrocytes by H2O2 in in vitro primary 
cultures.  Although  DJ-1-knockdown  SH-SY5Y  cells  were  mark-
edly  vulnerable  to  oxidative  stress,  treatment  with  glutathione 
S-transferase-tagged recombinant human DJ-1 protein (GST-DJ-1) 
significantly  inhibited  H2O2-induced  cell  death.  In  addition, 
GST-DJ-1 protein directly scavenged •OH. These results suggest 
that oxidative stress induces the release of astrocytic DJ-1 protein, 
which may contribute to astrocyte-mediated neuroprotection.
Introduction
DJ-1,  which  was  discovered  as  a  novel  oncogene  product  in 
collaboration  with  activated  small  GTP-binding  protein  ras,1  has 
recently been identified as the causative gene of familial Parkinson’s 
disease PARK7.2 DJ-1 has many functions, such as transcriptional 
factor,  molecular  chaperone,  etc.3-6  X-ray  crystallographic  and 
biological analyses have shown that wild-type DJ-1 protein forms 
a  homodimer.  In  addition,  these  analyses  have  also  shown  that 
L166P-mutation in DJ-1 protein, which was first found in a PARK7 
patient, disrupts dimer formation, resulting in a loss of function.7-11 
Furthermore, the cysteine residues in DJ-1 protein are oxidized, and 
the isoelectric point (pI) of DJ-1 is shifted to be more acidic.12 Thus, 
DJ-1 protein may play an important role in oxidative stress-mediated 
disorders.
Cerebral ischemia, one of the leading causes of death and long-
lasting disability, results from a transient or permanent reduction in 
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cerebral blood flow in a major brain artery.13,14 The production of 
reactive oxygen species (ROS) has been implicated in reperfusion 
injury after cerebral ischemia, and antioxidant enzymes are consid-
ered to be among the major mechanisms by which cells counteract 
the deleterious effect of ROS after cerebral ischemia.15,16 Previous 
studies  have  reported  that  activated  astrocytes  were  accumulated 
in  the  boundary  zone  (penumbra)  of  the  ischemic  core  in  the 
striatum.17,18 However, the function of DJ-1 protein in astrocytes 
remains unclear.
In  the  present  study,  to  clarify  the  effect  of  astrocytic  DJ-1 
protein under massive oxidative insult, we examined changes in the 
distribution of DJ-1 in astrocytes in the in vivo ischemic brain, DJ-1 
release from cultured astrocytes, and the effects of recombinant DJ-1 
protein  on  hydrogen  peroxide  (H2O2)-induced  death  in  normal 
and DJ-1-knockdown SH-SY5Y cells and on in vitro scavenging of 
hydroxyl radicals (•OH).
Results
Alteration of DJ-1 distribution in ischemic rat brains. To analyze 
changes  in  DJ-1  in  the  brain  under  oxidative  stress,  we  used  an 
ischemic  rat  model  that  had  been  subjected  to  middle  cerebral 
artery  occlusion  (MCAO)  and  reperfusion.  First,  we  investigated 
MCAO-induced injury using magnetic resonance (MR) imaging. In 
sham-operated rats, an infarct lesion was not detected as MR signal 
on T2-weighted MR images. At 24 h after 2-h MCAO and reperfu-
sion, an infarct lesion, as represented by an area of hyperintensity 
(white), was markedly observed in the ipsilateral cortex and striatum 
(Fig.  1A).  Similar  neurodegeneration  was  observed  on  staining 
with  2,3,5-triphenyltetrazolium  chloride  (TTC)  (Fig.  1B).  Also, 
microtubule-associated protein-2 (MAP2)- and tyrosine hydroxylase 
(TH)-immunoreactivities of the ipsilateral striatum were markedly 
decreased in ischemic rats (Fig. 1C and D).
In  response  to  MCAO,  glial  fibrillary  acidic  protein  (GFAP)-
immunopositive  astrocytes  changed  to  the  reactive  form  in  the 
border  zone  (penumbral  region)  where  MAP2-immunoreactivity 
was lost in the striatum and cerebral cortex (Fig. 1E). On the other 
hand, although DJ-1-immunoreactivity was hardly detected in the 
ischemic core region, this immunoreactivity was markedly increased 
in the penumbral region (Fig. 1F).
Intensive  DJ-1  immunoreactive  astrocytes  after  MCAO  and 
reperfusion. To examine the change in DJ-1 in astrocytes in isch-
emic  rats,  we  performed  double-staining  using  antibodies  against 
Figure 1.  Changes in neurons and astrocytes in the focal ischemic rat brain.  Representative photographs showing a coronal brain section 1.0 mm anterior 
from the bregma with T2-weighted MR imaging (A), TTC staining (a living cell marker, B), immunostaining using antibodies to MAP2 (a neural marker, C), 
TH (a dopaminergic neural marker, D), GFAP (an astrocytic marker, E) and DJ-1 (F).  Brains were prepared at 24 h after 2-h MCAO and reperfusion (left 
brain).  Sham-operated rats were used as the vehicle control (right brain).  In the upper panel of the right brain of ischemic rats, ipsilateral rectangular boxes 
show the ischemic core and penumbral region, which are separated by a dotted line (left lower panel, in C—F).  Contralateral boxes show a non-ischemic 
normal region.  Arrowhead indicates the same astrocyte in the ischemic core (lower panels in E and F).  Scale bars: 1 mm (upper panel in C) and 100 μm 
(lower panel in C).38             Oxidative Medicine and Cellular Longevity   2009; Vol. 2 Issue 1
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GFAP and DJ-1. At 24 h after reperfusion, GFAP-immunopositive 
astrocytes were activated and DJ-1-immunoreactivity was markedly 
increased in the boundary zone of the ischemic core in the striatum, 
compared to the contralateral side (Fig. 2).
Evaluation of H2O2-induced cell death. To analyze the effects of 
DJ-1, we used in vitro primary cultured astrocytes and neuroblastoma 
SH-SY5Y cells. In the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltet-
razolium  bromide  (MTT)  assay,  although  massive  cell  death  of 
SH-SY5Y cells was caused by H2O2 in a concentration-dependent 
manner,  astrocytes  were  relatively  resistant  to  H2O2-induced  cell 
death (Fig. 3A). To determine the endogenous DJ-1 protein level in 
astrocytes and SH-SY5Y cells, we performed western blotting using 
anti-DJ-1 antibody. The amount of DJ-1 protein in astrocytes was 
about six-fold greater than that in SH-SY5Y cells (Fig. 3B).
In addition, we measured the amount of DJ-1 protein, which was 
secreted  under  oxidative  conditions  from  astrocytes  into  cultured 
media. In normal cultured media, released DJ-1 protein was unde-
tectable. In contrast, DJ-1 protein was gradually and significantly 
released by exposure to H2O2 in a concentration-dependent manner 
(Fig. 4).
Protective  effects  of  recombinant  DJ-1  protein  in  SH-SY5Y 
cells. To clarify the function of released DJ-1 protein, we further 
examined  the  effects  of  recombinant  human  DJ-1  protein  on 
H2O2-treated SH-SY5Y cells (Fig. 5). In the present study, we gener-
ated  DJ-1-knockdown  SH-SY5Y  cells,  in  which  the  endogenous 
expression of human DJ-1 was suppressed by approximately 74%   
(Fig. 5B). In normal SH-SY5Y cells, cell death slightly occurred with 
25 μM H2O2 (Figure 5A and C). In contrast, the same concentra-
tion (25 μM) of H2O2 caused marked and significant cell death 
in  DJ-1-knockdown  cells.  Simultaneous  treatment  with  5  μM 
glutathione S-transferase-tagged recombinant human DJ-1 protein 
(GST-DJ-1),  but  not  glutathione  S-transferase  (GST),  rescued   
DJ-1-knockdown cells to the level in normal cells (Fig. 5A and D). 
In addition, a concentration-dependent curve of H2O2-induced cell 
death was further shifted to the right by treatment with GST-DJ-1, 
but not GST (Fig. 5A).
Effects  of  recombinant  DJ-1  protein  on  •OH  trapping  in 
vitro. To clarify the direct scavenging effect of recombinant DJ-1 
protein  against  ROS,  such  as  •OH,  we  further  performed  elec-
tron spin resonance (ESR) analysis using the spin-trapping agent 
5,5-dimethyl-1-pyrroline-N-oxide (DMPO) (Fig. 6). As an internal 
reference,  Mn2+  signal  was  detected  as  two  peaks  at  both  edges   
(Fig.  6A–D).  Although  no  marked  signal  was  detected  in  the 
absence of Fe2+, major four peaks with an intensity ratio of 1:2:2:1 
appeared at the mid-section between the Mn2+ signal, in the pres-
ence of H2O2 and Fe2+ (Fig. 6B). This characteristic quartet signal 
was almost completely suppressed by thiourea (data not shown), a 
specific •OH scavenger,19,20 suggesting that the quartet signal indi-
cates a DMPO-OH spin adduct. On the other hand, H2O2-induced 
DMPO-OH  signal  was  slightly  reduced  by  GST,  and  markedly 
reduced by GST-DJ-1 (Fig. 6).
Discussion
Oxidative stress is defined as an imbalance between ROS genera-
tion and the anti-oxidant capacity of a cell. The production of ROS, 
which occurs immediately and massively after focal ischemia and 
reperfusion,  is  followed  by  delayed  post-ischemic  inflammation 
Figure 2. Double-immunofluorescence staining for GFAP and DJ-1 in ischemic 
rat brain. Representative photographs showing brain sections, which were 
double-immunostained  with  antibodies  against  GFAP  (green,  left  panels) 
and DJ-1 (red, middle panels) in ischemic rats at 24 h after 2-h MCAO and 
reperfusion.  The  merged  images  are  shown  in  the  right  panels.  Arrows: 
Intensive DJ-1 immunoreactivity was detected in many reactive astrocytes in 
the penumbral region, but not in the contralateral normal region. Scale bar: 
100 μm.
Figure  3.  H2O2-induced  cell  death  in  SH-SY5Y  cells  and  astrocytes.   
(A) Primary cultured astrocytes and SH-SY5Y cells were exposed to H2O2 
at 0–300 μM for 24 h. Subsequently, cell viability was measured by the 
MTT assay. Each value is the mean±SEM of three determinations, based 
on  the  vehicle  control  as  100%.  Significance  (Bonferroni/Dunn  post  hoc 
comparisons after ANOVA): *p < 0.05, ***p < 0.001 vs. SH-SY5Y cells. 
(B) Immunoblotting assay for DJ-1 protein in cell lysates of SH-SY5Y cells and 
astrocytes.Release of neuroprotective DJ-1 from astrocytes
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and apoptosis, and these events are involved in the progression and 
expansion of neurodegeneration.21,22 We observed severe neuronal 
damage in the striatum and cerebral cortex at 24 h after 2-h MCAO 
and reperfusion (Fig. 1). We then performed a noninvasive evalua-
tion of the infarct area, using a 7T Unity Inova MR scanner, and 
detected the infarct lesion, as represented by an area of hyperinten-
sity (white), in the ipsilateral cortex and striatum. Subsequently, we 
examined MAP2- and TH-immunoreactivities and confirmed that 
these immunoreactivities corresponded to the results of MR imaging. 
It has been shown that severe neuronal damage leads to a strong and 
delayed activation of astrocytes and produces neurotrophic factors.17 
In this study, we also observed the accumulation of reactive astro-
cytes in the penumbral region of the ischemic core in the ipsilateral 
striatum and cerebral cortex (Figs. 1 and 2). Recently, it has been 
reported that DJ-1 protein was increased in the serum or plasma 
of  patients  with  breast  cancer,  melanoma,  familial  amyloidotic 
polyneuropathy,  stroke  and  Parkinson’s  disease. Therefore,  oxida-
tive stress may be related to the onset of these disorders.23-27 In the 
present study, we found that DJ-1 protein was actually released from 
astrocytes into the culture medium without cell death (Fig. 4). In 
addition, the amount of secreted DJ-1 protein was increased by expo-
sure to H2O2 in a concentration-dependent manner. Thus, oxidative 
stress activates astrocytes and induces DJ-1 secretion. 
In addition, astrocytes were more resistant to H2O2-induced cell 
death than SH-SY5Y cells, due to the higher expression of DJ-1 
protein (Fig. 3), while DJ-1-knockdown SH-SY5Y cells were more 
susceptible  to  exposure  to  H2O2.  H2O2-induced  cell  death  was 
significantly inhibited by simultaneous treatment with recombinant 
GST-DJ-1 protein, but not by GST-tag protein alone (Fig. 5). From 
these observations, we consider that astrocytes, which are rich in 
DJ-1 protein, are resistant to oxidative stress; and that DJ-1 protein 
Figure 4. H2O2-induced release of DJ-1 protein from astrocytes. Astrocytes 
were cultured with DMEM in the presence or absence of H2O2 (at 0–300 
μM)  for  24  h.  Subsequently,  when  media,  prepared  from  H2O2-treated 
astrocytic cultures, were assessed by immunoblotting, the amount of extra-
cellularly released DJ-1 protein was increased in a concentration-dependent 
manner. In the media without H2O2, however, extracellular DJ-1 protein was 
undetectable.
Figure 5. Protective effects of recombinant GST-DJ-1 against H2O2-induced 
oxidative stress in normal and DJ-1-knockdown SH-SY5Y cells. (A) Normal 
wild-type SH-SY5Y cells (Normal) and DJ-1-knockdown cells (DJ-1KD) were 
treated with H2O2, in the presence or absence of recombinant GST-tagged 
human DJ-1 protein (GST-DJ-1, at 1 μM) or GST-tag protein (GST, at 1 μM). 
After 24 h, cell viability was assessed by the MTT assay. (B) In DJ-1 KD cells, 
the expression of endogenous human DJ-1 was suppressed by approximately 
74% in comparison with normal cells. (C) Cell survival under exposure to 
25 μM H2O2, in the presence or absence of GST-DJ-1 or GST (each at   
1 μM). Data are the mean±SEM of four determinations, based on untreated 
cultures as 100%. Significance (Bonferroni/Dunn post hoc comparisons after 
ANOVA): *p < 0.05, ***p < 0.001 vs. treatment with the vehicle control. 
†p < 0.05, †††p < 0.001 vs. 25 μM H2O2 alone. Release of neuroprotective DJ-1 from astrocytes
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released  from  astrocytes  may  contribute  to  this  neuroprotection. 
However, since cerebral ischemia/reperfusion causes neuronal death, 
astrocytic release of DJ-1 may be a compensatory neuroprotective 
response.
Human and rat DJ-1 protein has three cysteine residues at amino 
acid numbers 46, 53 and 106 (C46, C53 and C106, respectively), 
and C106 is the most sensitive to oxidative stress.12 On the other 
hand, GST-tag protein involves four cysteine residues. Recent studies 
have suggested that H2O2 is produced by mitochondrial dysfunc-
tion, and •OH is easily generated in the presence of Fe2+ (ref. 28). 
•OH is one of most potent neurotoxic factors under ischemic insult 
and also causes protein oxidation. In the present study, •OH, which 
was generated in vitro by H2O2 and Fe2+, was directly scavenged 
partially  by  GST  alone  and  markedly  by  GST-DJ-1  protein.  A 
cysteine residue is oxidized from a reduced form (-SH) to sulphen-
ation (-SOH), sulphination (-SO2H) and sulphonation (-SO3H), 
in order of oxidative development. Thus, the oxidation of cysteine 
residues contributes to the direct scavenging of •OH. However, since 
GST alone did not inhibit the H2O2-induced cell death of SH-SY5Y 
cells, the scavenging of •OH by cysteine residues (cysteine oxidation) 
by itself may be insufficient to give a neuroprotective effect.
We previously found that recombinant GST-DJ-1 protein was 
taken up into dopaminergic neurons after intranigral microinjection 
and inhibited neural death in the in vivo brain of Parkinson’s disease-
model rats.9 Recent studies have reported that DJ-1 inhibits various 
apoptotic pathways, such as pyrimidine tract-binding protein-asso-
ciated splicing factor (PSF),29 apoptosis signal regulating kinase 1 
(ASK1),  death-domain-associated  protein  (Daxx),30  and/or  the 
reduction of homeodomain-interacting protein kinase 1 (HIPK1).31 
In addition, DJ-1 induces anti-oxidative episodes mediated by the 
stabilizing nuclear factor erythroid 2-related factor (Nrf2), which is a 
master regulator of antioxidant gene responses.32 Interestingly, DJ-1 
oxidation at C106 is necessary for DJ-1 to exert anti-apoptotic and 
molecular chaperoning responses, and massive oxidation may cause 
its inactivation.33,34 In brief, SOH- and SO2H-oxidation at C106 in 
DJ-1 protein may be active forms, while SO3H-peroxidation causes 
loss-of-function and an inactive form. Based on these observations, 
we consider that oxidized DJ-1 protein after MCAO and reperfusion 
may  induce  anti-apoptotic  responses  and  result  in  compensatory 
neuroprotection.
In  conclusion,  since  astrocytes  are  endogenously  rich  in  DJ-1 
protein, these glial cells may be relatively resistant to oxidative stress 
compared  to  neurons.  In  addition,  astrocytic  DJ-1  protein  was 
secreted by exposure to H2O2. Furthermore, recombinant GST-DJ-1 
protein  directly  trapped  •OH  and  inhibited  H2O2-induced  cell 
death. These  results  suggest  that  astrocytic  DJ-1  protein  may  be 
useful for the development of novel therapeutic targets in various 
oxidative stress-mediated disorders, including cerebral ischemia.
Materials and Methods
Preparation of recombinant human DJ-1 protein and anti-DJ-1 
antibody. Recombinant proteins, such as GST and GST-DJ-1, were 
expressed in and purified from Escherichia coli as described previ-
ously.1,6 The preparation and specificity of a rabbit polyclonal DJ-1 
antibody have been described previously.1,6,9
Rat model of focal cerebral ischemia. Wistar rats were purchased 
from  Japan  SLC,  Inc.  (Hamamatsu,  Japan).  The  animals  were 
acclimated  to  and  maintained  at  23°C  under  a  12-h  light/dark 
cycle (lights on 08:00-20:00 hours). Rats were housed in standard 
laboratory cages and had free access to food and water throughout 
the study period. All animal experiments were carried out in accor-
dance with the National Institutes of Health Guide for the Care 
and Use of Laboratory Animals, and the protocols were approved 
by the Committee for Animal Research at Kyoto Pharmaceutical 
University.
Figure 6. Direct •OH scavenging of recombinant GST-DJ-1 protein. Traces 
show typical spectra of DMPO-OH spin adducts generated from the vehicle 
control (Control, A) or H2O2/Fe2+, in the absence (H2O2, B) or presence 
of GST (GST, C) and GST-DJ-1 (DJ-1, D). (E) The amount of •OH was semi-
quantitatively  measured  as  the  formation  of  DMPO-OH  spin  adducts  by 
ESR spectrometry, after the reaction for exactly 1 min. Each value is the 
mean±SEM  of  three  determinations,  based  on  H2O2/Fe2+  as  100%  (B). 
Significance  (Bonferroni/Dunn  post  hoc  comparisons  after  ANOVA):   
**p < 0.01, ***p < 0.001 vs. signal intensity of H2O2/Fe2+, and †p < 
0.05 vs. signal intensity of H2O2/Fe2+ with GST.Release of neuroprotective DJ-1 from astrocytes
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Male Wistar rats weighing 260–300 g were used in the present 
study. Focal cerebral ischemia was induced by the intraluminal intro-
duction of a nylon thread35 as described previously.18 Briefly, animals 
were  anesthetized  with  4%  halothane  (Takeda  Pharmaceutical, 
Osaka, Japan) and maintained on 1.5% halothane using a facemask. 
After a midline neck incision was made, 20 mm of a 4-0 nylon thread 
with its tip rounded by heating and coated with silicon (Xantopren 
M;  Heraeus  Kulzer,  Hanau,  Germany)  was  inserted  into  the  left 
internal  carotid  artery  (ICA)  as  far  as  the  proximal  end  using  a 
globular stopper. The origin of MCA was then occluded by a silicon-
coated embolus. Anesthesia was discontinued, and the development 
of right hemiparesis with upper limb dominance was used as the 
criterion for ischemic insult. After 120 min of MCAO, the embolus 
was withdrawn to allow reperfusion of the ischemic region via the 
anterior  and  posterior  communicating  arteries.  Body  temperature 
was maintained at 37–37.5°C with a heating pad and lamp during 
surgery. In the sham operation, a midline neck incision was made to 
expose the arteries, but the nylon thread was not inserted into the 
carotid artery.
MR  imaging.  Rats  were  subjected  to  a  sham-operation  or  an 
operation on the MCAO. After 24 h, MR images of the rat heads 
were acquired with a 7 T Unity Inova MR scanner (Varian, Palo Alto, 
CA). A T2-weighted MR sequence was used with an acquisition 
repetition time of 2,000 ms, echo time of 40 ms, 35 x 35-mm2 field 
of view, and slice thickness of 1 mm. During the MR sessions, spon-
taneously breathing animals were anesthetized with 1.5% isoflurane 
in 50% O2 and 50% air. 
TTC staining. At 24 h after MCAO, brains were removed and 
cut into 2-mm-thick coronal sections. These sections were immersed 
in a 2% solution of TTC (Wako Pure Chemical Industries, Osaka, 
Japan) in saline at 37°C for 20 min, and then fixed in 4% paraform-
aldehyde in 100 mM phosphate buffer (PB) at 4°C.
Immunohistochemistry.  Rats  were  deeply  anesthetized  with 
pentobarbital (100 mg/kg, i.p.) and perfused through the aorta with 
150 mL of 10 mM phosphate-buffered saline (PBS), followed by 
300 mL of a cold fixative consisting of 4% paraformaldehyde in 100 
mM PB. After perfusion, brains were quickly removed and post-fixed 
for two days with 4% paraformaldehyde in 100 mM PB and then 
transferred to 15% sucrose solution in 100 mM PB containing 0.1% 
sodium azide at 4°C. The brain samples were cut into 20-μm thick 
slices using a cryostat and collected in 100 mM PBS containing 
0.3% Triton X-100 (PBS-T). The free-floating sections were treated 
with  0.3%  H2O2  in  PBS-T  to  eliminate  endogenous  peroxidase 
activity.  After  several  washes,  sections  were  incubated  for  three 
days at 4 °C with the following primary antibodies: MAP2 (dilu-
tion, 1:3,000; Sigma, St. Louis, MO) and TH (1:3,000; Sigma); 
mouse monoclonal antibodies against GFAP (1:3,000; Chemicon 
International, Temecula, CA); rabbit polyclonal antibodies against 
DJ-1 (1:10,000). After several washes, sections were incubated with 
biotinylated antibodies against mouse or rabbit IgG (1:2,000; Vector 
Laboratories, Burlingame, CA) for 2 h at room temperature. The 
sections were then incubated with 1:4,000 avidin peroxidase (ABC 
Elite kit, Vector Laboratories) for 1 h at room temperature. All of the 
sections were washed several times with PBS-T after each incubation, 
and  labeling  was  then  revealed  by  3,3’-diaminobenzidine  (DAB; 
Dojindo Laboratories, Kumamoto, Japan), with nickel ammonium, 
which yielded a dark blue color.
Double-immunofluorescence staining. For double-immunoflu-
orescence staining, sections were simultaneously incubated for three 
days at 4 °C with the following primary antibodies: mouse mono-
clonal antibody against GFAP (1:1,000; Chemicon Int.) and rabbit 
polyclonal  anti-DJ-1  antibody  (1:5,000).  Reactivity  with  primary 
antibody  was  detected  with  anti-mouse  IgG  antibody  conjugated 
with Alexa Fluor 488 or anti-rabbit IgG antibody conjugated with 
Alexa  Fluor  546  (each  diluted  1:500;  Molecular  Probes,  Eugene, 
OR) for 2 h at room temperature. Fluorescence was then detected 
using a laser scanning confocal microscope (LSM410, Carl Zeiss, 
Jena, Germany).
Cell culture and detection of extracellular DJ-1 protein. The 
human neuroblastoma cell line SH-SY5Y36 and rat primary astro-
cytes37  were  cultured  in  Dulbecco’s  modified  Eagle’s  medium 
(DMEM) supplemented with 10% (v/v) fetal calf serum (FCS), 50 
μg/mL penicillin and 100 μg/mL streptomycin and kept at 37 °C in 
humidified 5% CO2/95% air. Astrocytes were incubated in DMEM 
without FCS for 12 h and then in the presence or absence of H2O2 
(at 0–300 μM) for an additional 24 h. After incubation, the media 
were centrifuged at 15,000 rpm at 4 °C for 15 min to remove cells 
and debris, and transferred to a new tube. For the detection of extra-
cellular DJ-1 protein, the collected media were subjected to western 
blotting with anti-DJ-1 antibody.
Establishment of DJ-1-knockdown cells. We established a DJ-1-
knockdown  SH-SY5Y  cell  line  by  a  method  that  was  essentially 
similar  to  that  in  mouse  Flp-In3T3  cells.38  In  brief,  the  nucle-
otide sequence of the upper strand of the oligonucleotide used for 
construction of an siRNA vector targeting the human DJ-1 gene 
is  5’-GGATCCCGTCAAGGCTGGCATCAGGACAATTGATA- 
TCCGTTGTCCTGATGCCAGCCTTGATTTTTTCCAAAAG- 
CTT-3’. After oligonucleotides corresponding to the upper and lower 
strands of DNA were annealed, they were inserted into BamHI-
HindIII sites of pRNA-U6.1/Neo. These plasmids were transfected 
into human SH-SY5Y cells by the calcium phosphate precipitation 
method, and the cells were cultured in RPMI-1640 medium in the 
presence of 400 μg/mL G418 for 14 days. Cells that were resistant to 
the drug were then selected, and the intrinsic expression of DJ-1 was 
checked by western blotting with an anti-human DJ-1 antibody.
Measurement  of  cell  viability.  To  evaluate  cell  viability,  we 
performed  MTT  (Dojindo  Laboratories)  assay  as  an  index  of 
surviving cells. In living cells, MTT is converted to formazan, which 
has a specific absorption maximum. SH-SY5Y cells, in which endog-
enous  DJ-1  expression  was  normal  or  knocked-down  by  siRNA 
vector, were seeded at 3 x 104 cells/well in a 96-microwell plate, and 
treated with H2O2 (at 0–300 μM) 24 h after plating. At 24 h after 
treatment, the culture medium was changed to a medium containing 
5 mg/mL MTT, and the cells were incubated for an additional 4 h. 
They were then mixed thoroughly with an equal volume of isopro-
panol/0.04 M HCl, and sonicated to dissolve formazan completely. 
Absorbance was then measured at 570 nm with a microplate reader 
(BioRad Laboratories, Hercules, CA).
Analysis of ESR. •OH formation was monitored by ESR spec-
trometry with DMPO (Labotec Ltd., Tokyo, Japan), a spin-trapping 
agent. In a final volume of 200 μL of 100 mM PB, recombinant 
protein such as GST-DJ-1 (5 μM) or GST (5 μM) was added to 
the  reaction  mixture  containing  diethylene-triamine  pentaacetic 
acid  (25  μM),  FeSO4  (12.5  μM),  H2O2  (1  μM)  and  DMPO   Release of neuroprotective DJ-1 from astrocytes
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(22.5 mM). These recombinant proteins and reagents were solubi-
lized in Milli Q water. The reaction mixture was transferred to a flat 
quartz cuvette and placed in the cavity of an X-band JEOL RFR-30 
Radical Analyzer system (JEOL Ltd., Tokyo, Japan). •OH, which was 
generated by Fenton’s reaction between Fe2+ and H2O2, was trapped 
by DMPO, and the stable adduct DMPO-OH was measured exactly 
1 min after the addition of DMPO. The Mn2+-derived split signal 
was used as the internal standard. Typical instrument settings were as 
follows: incident-microwave 4 mW, modulation-amplitude 0.03 mT, 
time-constant 0.10 s, and sweeprate 5 mT/min.
Statistical  analysis.  Results  are  presented  as  the  mean  ±  stan-
dard error of the mean (SEM). The significance of differences was 
determined by an analysis of variance (ANOVA). Further post hoc 
comparisons  were  performed  using  Bonferroni/Dunn  tests  (Stat 
View; Abacus Concepts, Berkeley, CA).
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